Paul Mahon Insider Trades & Stock Holdings

EVP & GENERAL COUNSEL · United Therapeutics Corporation · Latest filing Jun 18, 2026

Paul Mahon, EVP & GENERAL COUNSEL at United Therapeutics Corporation has 2 Form 4 trades on file since Jun 18, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($4.49M), net -$4.49M. Latest filing: disposed of 8.30K shares of $UTHR on Jun 18, 2026 at $541.55.

Trades on file

2

Open-market bought

$0

Open-market sold

$4.49M

Net open-market

-$4.49M

Latest filing

Jun 18, 2026

All insider trades by Paul Mahon

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 18, 2026	$UTHR	Sell (Open-market sale) 10b5-1	8.30K	$541.55	$4.49M			+1.3%	-1.4%		EVP & GENERAL COUNSEL		—
Jun 18, 2026	$UTHR	Buy (Option exercise)	8.30K	$146.03	$1.21M			+1.3%	-1.4%		EVP & GENERAL COUNSEL		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Paul Mahon traded

• $UTHR

Frequently asked questions

Has Paul Mahon been buying or selling stock?

Paul Mahon has 0 open-market purchases and 1 open-market sale on file, net -$4.49M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Paul Mahon's latest insider trade?

disposed of 8.30K shares of $UTHR on Jun 18, 2026 at $541.55.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.